MICHAEL BRAUN to Colorectal Neoplasms
This is a "connection" page, showing publications MICHAEL BRAUN has written about Colorectal Neoplasms.
Connection Strength
2.027
-
Exploring perceptual disparities: A study on the level of understanding of colorectal cancer care among patients and healthcare professionals. Int J Colorectal Dis. 2026 Jan 08; 41(1):22.
Score: 0.152
-
A clinical rule-based indicator to identify recurrence of colorectal cancer after curative resection using linked routinely collected national data. Cancer Epidemiol. 2026 Feb; 100:102962.
Score: 0.151
-
Overall Survival for Bevacizumab Therapy in Metastatic Colorectal Cancer: An Updated Analysis of the TRAVASTIN Study. Clin Colorectal Cancer. 2026 03; 25(1):115-124.
Score: 0.151
-
Value of hospital administrative data linked to national cancer registry records to identify metastatic disease at time of primary diagnosis in colorectal cancer patients: a study using national data in England. BMC Cancer. 2025 Mar 06; 25(1):407.
Score: 0.144
-
Oncological Outcomes From Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Metastases. Clin Colorectal Cancer. 2025 06; 24(2):166-179.
Score: 0.141
-
Longitudinal Follow-Up of the Psychological Well-Being of Patients with Colorectal Cancer: Final Analysis of PICO-SM. Curr Oncol. 2024 12 11; 31(12):7903-7913.
Score: 0.141
-
Is early-onset colorectal cancer an evolving pandemic? Real-world data from a tertiary cancer center. Oncologist. 2024 12 06; 29(12):e1680-e1691.
Score: 0.141
-
Protocol for the CoNoR Study: A prospective multi-step study of the potential added benefit of two novel assessment tools in colorectal liver metastases technical resectability decision-making. BMJ Open. 2023 03 30; 13(3):e059369.
Score: 0.126
-
Modification to Systemic Anticancer Therapy at the Start of the COVID-19 Pandemic and its Overall Impact on Survival Outcomes in Patients with Colorectal Cancer. Clin Colorectal Cancer. 2022 06; 21(2):e117-e125.
Score: 0.115
-
Inhibition of WEE1 Is Effective in TP53- and RAS-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitoring. J Clin Oncol. 2021 11 20; 39(33):3705-3715.
Score: 0.113
-
The impact of the first peak of the COVID-19 pandemic on colorectal cancer services in England and Wales: A national survey. Colorectal Dis. 2021 07; 23(7):1733-1744.
Score: 0.109
-
The Impact of Changes in Service Delivery in Patients With Colorectal Cancer During the Initial Phase of the COVID-19 Pandemic. Clin Colorectal Cancer. 2021 06; 20(2):e120-e128.
Score: 0.107
-
Early Adaptation of Colorectal Cancer Cells to the Peritoneal Cavity Is Associated with Activation of "Stemness" Programs and Local Inflammation. Clin Cancer Res. 2021 02 15; 27(4):1119-1130.
Score: 0.107
-
Prospective study of change in liver function and fat in patients with colorectal liver metastases undergoing preoperative chemotherapy: protocol for the CLiFF Study. BMJ Open. 2020 09 23; 10(9):e027630.
Score: 0.105
-
Role of Emergency Laparoscopic Colectomy for Colorectal Cancer: A Population-based Study in England. Ann Surg. 2019 07; 270(1):172-179.
Score: 0.097
-
Effect of public reporting of surgeons' outcomes on patient selection, "gaming," and mortality in colorectal cancer surgery in England: population based cohort study. BMJ. 2018 May 02; 361:k1581.
Score: 0.089
-
Maintaining oxaliplatin therapy after hypersensitivity reactions: real-world experience with a desensitisation protocol. Clin Exp Med. 2026 Jan 21; 26(1):118.
Score: 0.038